Cargando…
Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa
Selective serotonin reuptake inhibitors (SSRI) are the most prescribed antidepressant medications for the treatment of depression and other psychiatric disorders due to their efficacy, tolerability, and safety profile. The dermatological side-effects or cutaneous reactions due to SSRI class of antid...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154162/ https://www.ncbi.nlm.nih.gov/pubmed/35656231 http://dx.doi.org/10.4103/ijd.ijd_1140_20 |
_version_ | 1784717983990415360 |
---|---|
author | Godi, Sangha M Singh, Lokesh K |
author_facet | Godi, Sangha M Singh, Lokesh K |
author_sort | Godi, Sangha M |
collection | PubMed |
description | Selective serotonin reuptake inhibitors (SSRI) are the most prescribed antidepressant medications for the treatment of depression and other psychiatric disorders due to their efficacy, tolerability, and safety profile. The dermatological side-effects or cutaneous reactions due to SSRI class of antidepressants is rare. Though there were few case reports of SSRI-induced rash due to fluoxetine, paroxetine, and sertraline, the evidence associated with escitalopram, the highly prescribed antidepressant is comparatively less. The identification and reporting of the drug-related side-effects/adverse drug reactions either serious or non-serious is very important as it will be helpful in understanding, reviewing, and educating the drug-related information before starting medication to the patient. |
format | Online Article Text |
id | pubmed-9154162 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-91541622022-06-01 Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa Godi, Sangha M Singh, Lokesh K Indian J Dermatol Case Report Selective serotonin reuptake inhibitors (SSRI) are the most prescribed antidepressant medications for the treatment of depression and other psychiatric disorders due to their efficacy, tolerability, and safety profile. The dermatological side-effects or cutaneous reactions due to SSRI class of antidepressants is rare. Though there were few case reports of SSRI-induced rash due to fluoxetine, paroxetine, and sertraline, the evidence associated with escitalopram, the highly prescribed antidepressant is comparatively less. The identification and reporting of the drug-related side-effects/adverse drug reactions either serious or non-serious is very important as it will be helpful in understanding, reviewing, and educating the drug-related information before starting medication to the patient. Wolters Kluwer - Medknow 2022 /pmc/articles/PMC9154162/ /pubmed/35656231 http://dx.doi.org/10.4103/ijd.ijd_1140_20 Text en Copyright: © 2022 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Godi, Sangha M Singh, Lokesh K Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa |
title | Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa |
title_full | Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa |
title_fullStr | Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa |
title_full_unstemmed | Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa |
title_short | Escitalopram-Induced Skin Rash: Dermatitis Medicamentosa |
title_sort | escitalopram-induced skin rash: dermatitis medicamentosa |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154162/ https://www.ncbi.nlm.nih.gov/pubmed/35656231 http://dx.doi.org/10.4103/ijd.ijd_1140_20 |
work_keys_str_mv | AT godisangham escitalopraminducedskinrashdermatitismedicamentosa AT singhlokeshk escitalopraminducedskinrashdermatitismedicamentosa |